% | $
Quotes you view appear here for quick access.

Biogen Inc. Message Board

  • onwardthroughthefog2003 onwardthroughthefog2003 Oct 18, 2012 9:07 AM Flag

    Is this something or nothing and a good buying opportunity?

    Biogen Idec receives notification of PDUFA date extension
    Co announced that the FDA has extended the initial PDUFA date for its review of the New Drug Application for the marketing approval of BG-12, the company's oral therapeutic candidate for the treatment of multiple sclerosis. The 3 month extension is a standard extension period.

296.46-0.08(-0.03%)Oct 26 4:00 PMEDT